| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $555,025 | +13,524 | +20% | $41.04 | 80,781 | 02 Mar 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $2,394,695 | -13,524 | -17% | $177.07 | 67,257 | 02 Mar 2023 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $110,439 | +2,691 | +4% | $41.04 | 69,948 | 02 Mar 2023 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $478,783 | -2,691 | -3.8% | $177.92 | 67,257 | 02 Mar 2023 | Direct | F1, F2, F4 |
| holding | SGEN | Common Stock | 119,471 | 02 Mar 2023 | by Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -13,524 | -42% | $0.000000 | 18,906 | 02 Mar 2023 | Common Stock | 13,524 | $41.04 | Direct | F5 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -2,691 | -14% | $0.000000 | 16,215 | 02 Mar 2023 | Common Stock | 2,691 | $41.04 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 74 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2023. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $176.58 to $177.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $177.60 to $178.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Options vested at a rate of 25% on 8/19/14 and monthly thereafter until all the options were fully vested on 8/19/17. |